Repligen (RGEN) Financials

$111.74 +3.22 (+2.97%)

Closing price 05/20/2026 04:00 PM Eastern

Extended Trading

$109.64 -2.10 (-1.88%)

As of 04:24 AM Eastern

Annual Income Statements for Repligen

This table shows Repligen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	9.35	221	28	17	21	60	128	186	36	-26	49
Consolidated Net Income / (Loss)	9.35	12	28	17	21	60	128	186	36	-26	49
Net Income / (Loss) Continuing Operations	9.35	221	28	17	21	60	128	186	36	-26	49
Total Pre-Tax Income	13	12	7.25	21	26	59	154	219	57	-27	62
Total Operating Income	14	16	14	26	36	70	167	225	48	-35	55
Total Gross Profit	48	162	74	108	151	210	391	456	278	275	386
Total Revenue	84	209	141	194	270	366	671	802	632	634	738
Operating Revenue	84	209	141	194	270	366	671	802	632	634	738
Total Cost of Revenue	35	47	67	87	119	157	279	346	354	360	352
Operating Cost of Revenue	35	47	67	87	119	157	279	346	354	360	352
Total Operating Expenses	35	-63	60	82	115	140	224	231	231	310	331
Selling, General & Admin Expense	25	31	52	66	96	120	184	216	219	263	291
Research & Development Expense	5.74	7.36	8.67	16	19	20	34	44	43	43	54
Other Special Charges / (Income)	4.08	3.24	-	-	-	-	5.87	-29	-31	3.19	-14
Total Other Income / (Expense), net	-0.34	-4.28	-6.76	-4.55	-9.93	-11	-14	-5.53	9.00	8.08	7.22
Interest Expense	0.03	3.77	6.44	6.71	15	11	11	1.16	15	21	22
Interest & Investment Income	0.14	0.35	0.37	1.90	5.32	1.74	0.18	6.98	24	36	28
Other Income / (Expense), net	-0.45	-0.86	-0.69	0.26	-0.31	-1.58	-2.60	-11	0.05	-7.02	1.16
Income Tax Expense	4.08	0.01	-21	4.82	4.74	-0.71	25	33	21	-1.52	13
Basic Earnings per Share	$0.28	$0.35	$0.74	$0.38	$0.44	$1.14	$2.33	$3.35	$0.64	($0.46)	$0.87
Weighted Average Basic Shares Outstanding	32.88M	33.57M	38.23M	43.77M	48.34M	52.55M	55.02M	55.46M	55.72M	55.94M	56.23M
Diluted Earnings per Share	$0.28	$0.34	$0.72	$0.37	$0.44	$1.11	$2.24	$3.24	$0.63	($0.46)	$0.86
Weighted Average Diluted Shares Outstanding	33.58M	34.10M	39.15M	45.47M	49.21M	53.89M	57.26M	57.46M	56.38M	55.94M	56.56M
Weighted Average Basic & Diluted Shares Outstanding	33.40M	33.40M	38.30M	43.70M	52.08M	54.77M	55.33M	55.56M	55.77M	56.15M	56.33M

This table shows Repligen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	17	-16	3.30	5.71	-0.65	-34	5.83	15	15	13	8.33
Consolidated Net Income / (Loss)	17	-16	3.30	5.71	-0.65	-34	5.83	15	15	13	8.33
Net Income / (Loss) Continuing Operations	17	-16	3.30	5.71	-0.65	-34	5.83	15	15	13	8.33
Total Pre-Tax Income	11	1.87	3.70	9.03	-1.15	-39	7.94	18	17	19	1.77
Total Operating Income	4.69	9.87	3.75	5.47	-7.83	-37	6.58	14	17	18	16
Total Gross Profit	37	78	77	82	77	39	91	91	101	104	108
Total Revenue	141	167	153	159	155	168	169	182	189	198	194
Operating Revenue	141	167	153	159	155	168	169	182	189	198	194
Total Cost of Revenue	105	88	76	77	77	129	78	91	88	94	86
Operating Cost of Revenue	105	88	76	77	77	129	78	91	88	94	86
Total Operating Expenses	32	69	73	76	85	75	85	77	84	86	92
Selling, General & Admin Expense	56	58	62	65	76	60	71	71	74	74	77
Research & Development Expense	11	10	11	11	9.71	12	12	14	14	13	14
Restructuring Charge	-	-	-	-	-	-	1.97	-	-	-	1.50
Other Special Charges / (Income)	-34	0.70	0.00	0.00	0.00	3.19	0.00	-7.94	-4.15	-1.52	-0.15
Total Other Income / (Expense), net	6.69	-8.01	-0.06	3.56	6.68	-2.11	1.37	4.32	0.29	1.25	-14
Interest Expense	0.41	14	5.03	5.12	5.12	5.46	5.25	5.35	5.41	5.50	5.58
Interest & Investment Income	6.66	6.02	8.99	9.41	9.13	8.29	7.31	6.59	6.92	6.75	6.34
Other Income / (Expense), net	0.44	-0.08	-4.02	-0.74	2.68	-4.94	-0.70	3.09	-1.22	-0.01	-15
Income Tax Expense	-5.54	18	0.40	3.31	-0.50	-4.74	2.11	3.35	2.20	5.83	-6.56
Basic Earnings per Share	$0.30	($0.30)	$0.06	$0.10	($0.01)	($0.61)	$0.10	$0.26	$0.27	$0.24	$0.15
Weighted Average Basic Shares Outstanding	55.77M	55.72M	55.79M	55.88M	56.01K	55.94M	56.12M	56.23M	56.27M	56.23M	56.35M
Diluted Earnings per Share	$0.30	($0.29)	$0.06	$0.10	($0.01)	($0.61)	$0.10	$0.26	$0.26	$0.24	$0.15
Weighted Average Diluted Shares Outstanding	56.94M	56.38M	56.53M	56.43M	56.01K	55.94M	56.56M	56.51M	56.53M	56.56M	56.67M
Weighted Average Basic & Diluted Shares Outstanding	55.83M	55.77M	55.88M	56.01M	56.03M	56.15M	56.18M	56.26M	56.29M	56.33M	56.41M

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	19	68	51	20	341	180	-113	-80	228	6.03	-191
Net Cash From Operating Activities	15	7.52	17	33	67	63	119	172	114	175	117
Net Cash From Continuing Operating Activities	15	7.52	17	33	65	58	119	172	115	175	116
Net Income / (Loss) Continuing Operations	9.35	12	28	17	21	60	128	186	36	-26	49
Consolidated Net Income / (Loss)	9.35	12	28	17	21	60	128	186	36	-26	49
Depreciation Expense	4.59	5.33	11	16	21	27	38	51	69	70	79
Amortization Expense	-	2.27	3.98	4.25	7.54	11	22	1.82	2.45	16	17
Non-Cash Adjustments To Reconcile Net Income	3.60	0.50	6.81	7.59	16	13	30	33	59	52	36
Changes in Operating Assets and Liabilities, net	-2.49	-12	-32	-11	-0.73	-53	-100	-100	-51	64	-64
Net Cash From Investing Activities	4.79	-49	-99	-14	-205	-201	-221	-233	-123	-86	-298
Net Cash From Continuing Investing Activities	4.79	-49	-99	-14	-205	-201	-221	-233	-123	-86	-298
Purchase of Property, Plant & Equipment	-2.63	-4.33	-5.45	-12	-19	-22	-67	-85	-36	-26	-24
Acquisitions	-	-45	-113	-2.15	-187	-179	-154	-49	-189	-62	-73
Purchase of Investments	-20	-24	-0.05	-	-	0.00	0.00	-100	0.00	0.00	-200
Sale of Property, Plant & Equipment	-	0.05	-	-	-	-	-	-	0.00	0.00	0.24
Sale and/or Maturity of Investments	28	23	20	-	-	-	0.00	0.00	102	0.00	0.00
Other Investing Activities, net	-	-	-	-	-	0.00	0.00	0.11	0.03	1.29	-2.40
Net Cash From Financing Activities	0.77	112	130	3.41	485	306	0.96	-13	249	-83	-15
Net Cash From Continuing Financing Activities	0.77	112	130	3.41	485	306	0.96	-13	249	-83	-15
Repayment of Debt	-	-	-	-0.01	-115	0.00	-0.02	-0.03	-7.30	-70	0.00
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-14	0.00	0.00
Issuance of Debt	-	111	-	0.00	278	-	0.00	0.00	290	0.00	0.00
Other Financing Activities, net	0.87	1.84	0.64	3.42	0.68	8.14	0.98	-13	-19	-13	-15
Effect of Exchange Rate Changes	-1.88	-2.30	2.38	-2.08	-3.19	13	-12	-5.87	-12	-0.08	4.93
Cash Interest Paid	-	1.22	2.44	2.44	1.48	1.07	1.07	1.03	0.00	0.00	0.00
Cash Income Taxes Paid	4.95	3.99	4.02	4.05	6.51	10	17	34	27	19	21

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	27	121	29	29	-25	-27	-60	12	40	-183	19
Net Cash From Operating Activities	39	29	45	42	49	39	15	29	48	26	28
Net Cash From Continuing Operating Activities	39	29	45	42	49	39	15	29	48	24	28
Net Income / (Loss) Continuing Operations	3.15	-16	3.30	6.92	2.94	-34	5.83	15	15	13	8.33
Consolidated Net Income / (Loss)	3.15	-16	3.30	6.92	2.94	-34	5.83	15	15	13	8.33
Depreciation Expense	20	17	17	17	18	18	19	20	20	20	20
Amortization Expense	0.46	1.08	8.20	13	17	-8.79	8.52	4.12	19	-10	9.15
Non-Cash Adjustments To Reconcile Net Income	11	28	8.81	30	40	27	8.34	15	-1.59	21	13
Changes in Operating Assets and Liabilities, net	4.77	-1.06	7.49	-24	-28	37	-26	-26	-4.07	-20	-22
Net Cash From Investing Activities	-8.77	-170	-8.36	-7.40	-5.86	-65	-74	-7.84	-7.78	-209	-3.99
Net Cash From Continuing Investing Activities	-8.77	-170	-8.36	-7.40	-5.86	-65	-74	-7.84	-7.78	-209	-3.99
Purchase of Property, Plant & Equipment	-8.39	-11	-8.35	-4.81	-6.98	-5.54	-3.56	-7.10	-4.70	-8.15	-4.71
Acquisitions	-0.41	-159	-0.03	-2.59	-0.16	-59	-71	-0.74	-0.68	-0.53	-0.24
Purchase of Investments	-	-	-	-	-	-	0.00	-	-	-	-65
Sale of Property, Plant & Equipment	-	-	0.01	-	-	-	0.04	-	-	0.20	0.00
Sale and/or Maturity of Investments	-	-	0.00	-	-	-	0.00	-	-	-	66
Other Investing Activities, net	-	-	-	-	-	-	0.00	-	-	-	-0.42
Net Cash From Financing Activities	-0.78	268	-8.97	-5.77	-70	1.45	-5.03	-10	-0.24	0.20	-5.54
Net Cash From Continuing Financing Activities	-0.78	268	-8.97	-5.77	-70	1.45	-5.03	-10	-0.24	0.20	-5.54
Other Financing Activities, net	-0.74	-0.33	-8.84	-5.61	0.03	1.45	-5.03	-10	-0.24	0.20	-5.54
Effect of Exchange Rate Changes	-2.56	-6.74	1.92	-0.49	0.96	-2.47	4.01	-	-0.19	0.12	-0.15

This table presents Repligen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	146	289	744	775	1,400	1,903	2,358	2,532	2,831	2,830	2,950
Total Current Assets	103	184	243	276	642	902	932	998	1,111	1,066	1,137
Cash & Equivalents	54	122	174	194	528	717	604	523	751	757	566
Short-Term Investments	18	20	-	-	-	-	0.00	100	-	0.00	202
Accounts Receivable	11	16	28	36	44	71	117	116	124	134	159
Inventories, net	18	25	39	42	55	95	184	238	202	143	170
Prepaid Expenses	2.10	1.64	2.28	3.90	5.92	19	26	20	34	32	41
Plant, Property, & Equipment, net	14	15	22	32	48	67	125	191	207	198	187
Total Noncurrent Assets	29	90	478	467	710	934	1,302	1,343	1,512	1,566	1,626
Goodwill	14	60	327	327	468	618	860	856	987	1,031	1,114
Intangible Assets	13	30	145	135	213	287	337	361	407	398	386
Noncurrent Deferred & Refundable Income Taxes	-	-	0.00	4.36	2.92	2.48	1.90	0.84	1.53	0.75	0.69
Other Noncurrent Operating Assets	-	-	6.23	0.17	26	26	102	126	117	136	124
Total Liabilities & Shareholders' Equity	146	289	744	775	1,400	1,903	2,358	2,532	2,831	2,830	2,950
Total Liabilities	23	120	152	159	340	374	608	621	866	857	844
Total Current Liabilities	19	21	25	130	48	319	375	404	165	127	136
Short-Term Debt	-	-	0.00	103	0.00	244	255	299	82	17	5.05
Accounts Payable	6.72	5.06	7.28	10	11	17	36	28	20	32	30
Accrued Expenses	12	16	18	16	33	53	75	71	57	62	79
Other Current Liabilities	-	-	-	-	3.56	5.25	8.30	6.96	5.63	15	22
Total Noncurrent Liabilities	4.71	99	127	29	292	55	233	217	701	730	708
Long-Term Debt	-	95	99	-	233	-	-	0.00	510	526	542
Noncurrent Deferred & Payable Income Tax Liabilities	-	2.10	25	25	30	27	33	23	39	23	22
Other Noncurrent Operating Liabilities	4.71	1.70	2.34	4.13	29	28	200	194	152	182	143
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973	2,106
Total Preferred & Common Equity	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973	2,106
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973	2,106
Common Stock	203	242	629	643	1,069	1,461	1,573	1,548	1,570	1,618	1,652
Retained Earnings	-72	-60	-32	-16	5.84	66	194	397	433	407	456
Accumulated Other Comprehensive Income / (Loss)	-8.57	-14	-6.36	-12	-15	2.09	-17	-34	-38	-53	-2.53

This table presents Repligen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	2,463	2,548	2,557	2,523	2,854	2,866	2,831	2,852	2,902	2,924	2,931
Total Current Assets	953	1,022	1,000	980	1,131	1,157	1,132	1,032	1,057	1,096	1,161
Cash & Equivalents	573	517	604	631	781	809	784	697	709	749	583
Short-Term Investments	-	101	0.00	0.00	-	-	-	-	-	-	202
Accounts Receivable	118	133	120	106	116	123	129	147	157	149	152
Inventories, net	243	245	241	211	198	191	182	153	156	160	179
Prepaid Expenses	20	25	35	32	36	33	36	35	35	38	46
Plant, Property, & Equipment, net	174	193	203	202	206	205	203	196	193	189	173
Total Noncurrent Assets	1,335	1,334	1,355	1,341	1,517	1,505	1,496	1,624	1,651	1,638	1,596
Goodwill	851	856	871	869	986	986	988	1,082	1,114	1,113	1,107
Intangible Assets	360	353	358	350	394	386	381	409	406	395	368
Noncurrent Deferred & Refundable Income Taxes	1.76	0.85	1.76	1.55	0.87	0.68	0.10	0.74	0.80	0.86	1.36
Other Noncurrent Operating Assets	122	123	124	120	136	132	128	132	130	129	120
Total Liabilities & Shareholders' Equity	2,463	2,548	2,557	2,523	2,854	2,866	2,831	2,852	2,902	2,924	2,931
Total Liabilities	627	621	600	549	888	882	814	867	840	841	825
Total Current Liabilities	411	417	388	379	182	175	108	152	123	131	126
Short-Term Debt	298	313	302	299	94	83	14	34	5.17	5.11	5.23
Accounts Payable	25	26	24	19	19	21	21	27	26	29	35
Accrued Expenses	75	69	60	58	59	58	61	76	76	77	65
Other Current Liabilities	13	7.96	2.89	3.32	9.78	12	12	15	16	19	21
Total Noncurrent Liabilities	217	205	212	170	707	707	706	715	717	709	699
Long-Term Debt	-	-	-	-	514	518	522	530	534	538	547
Noncurrent Deferred & Payable Income Tax Liabilities	23	22	22	15	37	34	34	24	23	20	15
Other Noncurrent Operating Liabilities	193	182	190	156	156	155	150	161	160	151	137
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,835	1,927	1,957	1,974	1,966	1,984	2,017	1,985	2,062	2,083	2,105
Total Preferred & Common Equity	1,835	1,927	1,957	1,974	1,966	1,984	2,017	1,985	2,062	2,083	2,105
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,835	1,927	1,957	1,974	1,966	1,984	2,017	1,985	2,062	2,083	2,105
Common Stock	1,542	1,546	1,562	1,568	1,572	1,587	1,610	1,620	1,635	1,644	1,655
Retained Earnings	349	413	432	449	436	442	441	413	428	443	465
Accumulated Other Comprehensive Income / (Loss)	-55	-31	-37	-43	-43	-44	-35	-48	-1.72	-4.11	-14

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	31.46%	150.17%	-32.42%	37.38%	39.28%	35.53%	83.08%	19.54%	-21.11%	0.33%	16.36%
EBITDA Growth	20.23%	26.85%	22.36%	66.45%	38.67%	65.62%	111.87%	18.18%	-55.38%	-63.68%	251.76%
EBIT Growth	22.43%	13.48%	-11.88%	97.10%	36.26%	90.79%	141.26%	29.57%	-77.62%	-188.23%	233.68%
NOPAT Growth	22.19%	66.54%	243.29%	-63.23%	46.65%	139.18%	97.77%	36.43%	-84.29%	-182.09%	275.91%
Net Income Growth	14.38%	25.00%	142.73%	-41.39%	28.85%	179.88%	114.08%	44.95%	-80.86%	-171.68%	291.64%
EPS Growth	12.00%	21.43%	111.76%	-48.61%	18.92%	152.27%	101.80%	44.64%	-80.56%	-173.02%	286.96%
Operating Cash Flow Growth	-18.19%	-50.04%	132.03%	87.78%	105.11%	-6.83%	90.05%	44.59%	-33.80%	53.97%	-33.06%
Free Cash Flow Firm Growth	186.01%	-671.25%	-497.74%	103.51%	-1,776.49%	-14.70%	10.28%	103.23%	-2,964.87%	112.31%	-459.99%
Invested Capital Growth	-0.79%	149.14%	324.48%	1.59%	43.77%	39.79%	32.77%	13.13%	13.91%	-2.66%	7.26%
Revenue Q/Q Growth	6.44%	108.17%	-38.50%	-15.08%	29.98%	11.98%	13.14%	0.03%	-5.59%	2.99%	4.29%
EBITDA Q/Q Growth	6.25%	24.59%	11.23%	11.42%	2.12%	13.21%	17.80%	1.26%	-31.04%	-50.03%	44.28%
EBIT Q/Q Growth	7.80%	14.08%	0.75%	22.40%	-6.10%	18.94%	13.66%	6.48%	-54.40%	-481.76%	1,995.73%
NOPAT Q/Q Growth	11.04%	80.16%	37.53%	-34.48%	-5.01%	34.90%	6.56%	8.03%	-68.48%	-590.68%	14,434.10%
Net Income Q/Q Growth	7.64%	68.87%	33.72%	-28.25%	-8.67%	36.72%	7.92%	11.79%	-68.92%	-30.99%	2,713.23%
EPS Q/Q Growth	3.70%	78.95%	22.03%	-28.85%	-12.00%	35.37%	6.67%	11.72%	-68.50%	-39.39%	8,500.00%
Operating Cash Flow Q/Q Growth	11.88%	-15.67%	316.79%	-22.77%	22.00%	-4.28%	41.24%	7.67%	-22.36%	6.12%	-10.29%
Free Cash Flow Firm Q/Q Growth	21.51%	-154.90%	13.48%	-55.98%	1.40%	-3,065.94%	48.82%	118.27%	-9,817.70%	120.32%	22.37%
Invested Capital Q/Q Growth	-3.14%	49.13%	0.40%	1.28%	0.30%	29.92%	4.09%	1.67%	9.04%	-0.58%	0.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.80%	77.45%	52.53%	55.40%	55.93%	57.23%	58.35%	56.85%	44.03%	43.29%	52.32%
EBITDA Margin	21.44%	10.87%	19.68%	23.85%	23.75%	29.02%	33.58%	33.20%	18.78%	6.80%	20.55%
Operating Margin	16.48%	7.64%	9.92%	13.39%	13.35%	19.06%	24.94%	28.03%	7.54%	-5.53%	7.47%
EBIT Margin	15.94%	7.23%	9.43%	13.53%	13.24%	18.63%	24.55%	26.61%	7.55%	-6.64%	7.63%
Profit (Net Income) Margin	11.19%	5.59%	20.07%	8.56%	7.92%	16.36%	19.13%	23.20%	5.63%	-4.02%	6.62%
Tax Burden Percent	69.62%	99.91%	391.18%	77.52%	81.87%	101.20%	83.55%	84.86%	62.77%	94.37%	78.38%
Interest Burden Percent	100.78%	77.36%	54.42%	81.66%	73.11%	86.77%	93.26%	102.73%	118.76%	64.17%	110.76%
Effective Tax Rate	30.38%	0.09%	-291.18%	22.48%	18.13%	-1.20%	16.45%	15.14%	37.23%	0.00%	21.62%
Return on Invested Capital (ROIC)	19.52%	18.70%	17.15%	3.87%	4.61%	7.80%	11.37%	12.77%	1.77%	-1.38%	2.37%
ROIC Less NNEP Spread (ROIC-NNEP)	19.87%	25.78%	60.67%	8.15%	8.73%	10.56%	14.16%	14.16%	-0.57%	-0.88%	-0.23%
Return on Net Nonoperating Assets (RNNOA)	-11.55%	-10.68%	-9.69%	-1.11%	-2.06%	-3.18%	-3.55%	-2.61%	0.07%	0.08%	0.02%
Return on Equity (ROE)	7.97%	8.01%	7.46%	2.75%	2.56%	4.63%	7.82%	10.16%	1.84%	-1.30%	2.40%
Cash Return on Invested Capital (CROIC)	20.31%	-66.73%	-106.58%	2.29%	-31.30%	-25.38%	-16.78%	0.45%	-11.24%	1.32%	-4.64%
Operating Return on Assets (OROA)	9.70%	6.95%	2.58%	3.46%	3.29%	4.13%	7.73%	8.73%	1.78%	-1.49%	1.95%
Return on Assets (ROA)	6.81%	5.37%	5.49%	2.19%	1.97%	3.63%	6.02%	7.61%	1.33%	-0.90%	1.69%
Return on Common Equity (ROCE)	7.97%	8.01%	7.46%	2.75%	2.56%	4.63%	7.82%	10.16%	1.84%	-1.30%	2.40%
Return on Equity Simple (ROE_SIMPLE)	7.61%	6.92%	4.79%	2.70%	2.02%	3.92%	7.33%	9.73%	1.81%	-1.29%	0.00%
Net Operating Profit after Tax (NOPAT)	9.58	16	55	20	30	71	140	191	30	-25	43
NOPAT Margin	11.47%	7.64%	38.79%	10.38%	10.93%	19.29%	20.84%	23.79%	4.74%	-3.87%	5.86%
Net Nonoperating Expense Percent (NNEP)	-0.35%	-7.08%	-43.52%	-4.28%	-4.12%	-2.76%	-2.79%	-1.39%	2.34%	-0.50%	2.60%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.63%	1.17%	-0.98%	1.63%
Cost of Revenue to Revenue	42.20%	22.55%	47.47%	44.60%	44.07%	42.77%	41.65%	43.15%	55.97%	56.71%	47.68%
SG&A Expenses to Revenue	29.57%	14.76%	36.47%	33.86%	35.38%	32.66%	27.42%	26.93%	34.57%	41.51%	39.35%
R&D to Revenue	6.87%	3.52%	6.14%	8.15%	7.20%	5.51%	5.11%	5.48%	6.76%	6.81%	7.34%
Operating Expenses to Revenue	41.33%	-30.14%	42.61%	42.01%	42.58%	38.17%	33.41%	28.82%	36.49%	48.82%	44.85%
Earnings before Interest and Taxes (EBIT)	13	15	13	26	36	68	165	213	48	-42	56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	18	23	28	46	64	106	225	266	119	43	152
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.59	6.18	2.67	3.76	4.54	6.59	8.37	4.92	5.11	4.09	4.38
Price to Tangible Book Value (P/TBV)	9.74	13.13	13.23	15.08	12.71	16.17	26.51	13.53	17.59	14.83	15.23
Price to Revenue (P/Rev)	11.16	4.99	11.19	11.92	17.82	27.53	21.84	11.73	15.87	12.71	12.49
Price to Earnings (P/E)	99.73	4.73	55.75	139.20	224.91	168.26	114.14	50.55	282.01	0.00	188.65
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.00%	21.15%	1.79%	0.72%	0.44%	0.59%	0.88%	1.98%	0.35%	0.00%	0.53%
Enterprise Value to Invested Capital (EV/IC)	17.56	8.18	2.91	4.23	5.97	9.10	10.20	5.72	5.47	4.47	4.77
Enterprise Value to Revenue (EV/Rev)	10.28	4.77	10.66	11.46	16.69	26.24	21.32	11.32	15.62	12.37	12.20
Enterprise Value to EBITDA (EV/EBITDA)	47.93	43.84	54.17	48.03	70.29	90.42	63.48	34.10	83.20	182.00	59.35
Enterprise Value to EBIT (EV/EBIT)	64.46	65.91	113.08	84.68	126.11	140.82	86.82	42.54	206.90	0.00	159.86
Enterprise Value to NOPAT (EV/NOPAT)	89.60	62.42	27.49	110.34	152.69	136.00	102.29	47.60	329.94	0.00	208.23
Enterprise Value to Operating Cash Flow (EV/OCF)	57.04	132.45	86.30	67.83	67.11	153.45	120.10	52.74	86.73	44.76	76.68
Enterprise Value to Free Cash Flow (EV/FCFF)	86.11	0.00	0.00	186.00	0.00	0.00	0.00	1,363.80	0.00	334.54	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.56	0.17	0.17	0.22	0.16	0.15	0.16	0.30	0.28	0.26
Long-Term Debt to Equity	0.00	0.56	0.17	0.00	0.22	0.00	0.00	0.00	0.26	0.27	0.26
Financial Leverage	-0.58	-0.41	-0.16	-0.14	-0.24	-0.30	-0.25	-0.18	-0.12	-0.09	-0.11
Leverage Ratio	1.17	1.49	1.36	1.26	1.30	1.28	1.30	1.34	1.38	1.44	1.42
Compound Leverage Factor	1.18	1.15	0.74	1.03	0.95	1.11	1.21	1.37	1.64	0.92	1.57
Debt to Total Capital	0.00%	36.08%	14.37%	14.39%	18.01%	13.75%	12.73%	13.51%	23.17%	21.57%	20.63%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	14.39%	0.00%	13.75%	12.73%	13.51%	3.22%	0.68%	0.19%
Long-Term Debt to Total Capital	0.00%	36.08%	14.37%	0.00%	18.01%	0.00%	0.00%	0.00%	19.95%	20.89%	20.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	63.92%	85.63%	85.61%	81.99%	86.25%	87.27%	86.49%	76.83%	78.43%	79.38%
Debt to EBITDA	0.00	4.19	3.57	2.24	3.63	2.29	1.13	1.12	4.99	12.58	3.61
Net Debt to EBITDA	0.00	-2.05	-2.68	-1.95	-4.75	-4.46	-1.55	-1.22	-1.34	-4.98	-1.45
Long-Term Debt to EBITDA	0.00	4.19	3.57	0.00	3.63	0.00	0.00	0.00	4.30	12.19	3.57
Debt to NOPAT	0.00	5.97	1.81	5.14	7.88	3.45	1.83	1.57	19.79	-22.08	12.66
Net Debt to NOPAT	0.00	-2.91	-1.36	-4.48	-10.31	-6.70	-2.49	-1.71	-5.30	8.73	-5.10
Long-Term Debt to NOPAT	0.00	5.97	1.81	0.00	7.88	0.00	0.00	0.00	17.04	-21.38	12.54
Altman Z-Score	24.69	6.49	6.78	9.29	9.28	16.92	15.36	10.18	7.85	6.42	7.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.50	8.74	9.63	2.12	13.28	2.83	2.48	2.47	6.74	8.41	8.37
Quick Ratio	4.43	7.49	7.99	1.77	11.84	2.47	1.92	1.83	5.31	7.03	6.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	9.97	-57	-340	12	-200	-230	-206	6.65	-191	23	-84
Operating Cash Flow to CapEx	572.79%	175.72%	319.97%	275.61%	363.25%	278.89%	177.40%	202.85%	314.50%	683.08%	504.35%
Free Cash Flow to Firm to Interest Expense	311.58	-15.12	-52.86	1.78	-13.41	-21.34	-18.28	5.73	-12.56	1.13	-3.93
Operating Cash Flow to Interest Expense	470.41	2.00	2.71	4.88	4.50	5.82	10.55	148.09	7.51	8.46	5.46
Operating Cash Flow Less CapEx to Interest Expense	388.28	0.86	1.86	3.11	3.26	3.73	4.60	75.09	5.12	7.22	4.38
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.96	0.27	0.26	0.25	0.22	0.31	0.33	0.24	0.22	0.26
Accounts Receivable Turnover	8.62	15.25	6.45	6.11	6.81	6.37	7.10	6.86	5.26	4.91	5.04
Inventory Turnover	2.32	2.21	2.11	2.13	2.45	2.09	2.00	1.64	1.61	2.08	2.25
Fixed Asset Turnover	5.90	14.53	7.56	7.11	6.70	6.35	6.99	5.08	3.18	3.13	3.84
Accounts Payable Turnover	6.66	8.00	10.86	9.74	10.87	11.07	10.52	10.85	15.02	13.92	11.33
Days Sales Outstanding (DSO)	42.34	23.94	56.56	59.72	53.64	57.33	51.39	53.20	69.38	74.29	72.36
Days Inventory Outstanding (DIO)	157.29	165.37	173.38	171.40	148.78	174.60	182.66	223.10	227.19	175.14	162.49
Days Payable Outstanding (DPO)	54.81	45.65	33.60	37.48	33.58	32.98	34.69	33.65	24.30	26.22	32.22
Cash Conversion Cycle (CCC)	144.82	143.66	196.35	193.64	168.84	198.96	199.36	242.66	272.28	223.21	202.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	49	122	517	525	755	1,056	1,402	1,586	1,806	1,758	1,886
Invested Capital Turnover	1.70	2.45	0.44	0.37	0.42	0.40	0.55	0.54	0.37	0.36	0.41
Increase / (Decrease) in Invested Capital	-0.39	73	395	8.20	230	300	346	184	221	-48	128
Enterprise Value (EV)	859	996	1,506	2,223	4,511	9,610	14,294	9,076	9,880	7,850	9,003
Market Capitalization	932	1,043	1,581	2,313	4,815	10,083	14,643	9,401	10,039	8,064	9,224
Book Value per Share	$3.73	$4.99	$13.58	$14.04	$20.36	$29.06	$31.65	$34.41	$35.19	$35.21	$37.42
Tangible Book Value per Share	$2.90	$2.35	$2.74	$3.50	$7.28	$11.85	$9.99	$12.51	$10.22	$9.71	$10.76
Total Capital	123	264	691	719	1,293	1,773	2,005	2,209	2,557	2,515	2,653
Total Debt	0.00	95	99	103	233	244	255	299	593	543	547
Total Long-Term Debt	0.00	95	99	0.00	233	0.00	0.00	0.00	510	526	542
Net Debt	-73	-47	-75	-90	-305	-474	-349	-325	-159	-215	-220
Capital Expenditures (CapEx)	2.63	4.28	5.45	12	19	22	67	85	36	26	23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	21	44	56	56	110	208	269	278	199	239
Debt-free Net Working Capital (DFNWC)	84	163	218	249	594	827	812	892	1,029	956	1,007
Net Working Capital (NWC)	84	163	218	146	594	583	556	594	946	939	1,002
Net Nonoperating Expense (NNE)	0.24	4.28	26	3.53	8.13	11	11	4.69	-5.65	0.93	-5.66
Net Nonoperating Obligations (NNO)	-74	-47	-75	-90	-305	-474	-349	-325	-159	-215	-220
Total Depreciation and Amortization (D&A)	4.59	7.61	14	20	28	38	61	53	71	85	95
Debt-free, Cash-free Net Working Capital to Revenue	15.20%	10.19%	31.02%	28.64%	20.76%	30.00%	31.00%	33.53%	43.89%	31.37%	32.37%
Debt-free Net Working Capital to Revenue	101.12%	78.03%	154.05%	128.53%	219.62%	225.84%	121.05%	111.35%	162.70%	150.74%	136.35%
Net Working Capital to Revenue	101.12%	78.03%	154.05%	75.19%	219.62%	159.29%	82.98%	74.10%	149.66%	148.04%	135.67%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.28	$0.35	$0.74	$0.38	$0.44	$1.14	$2.33	$3.35	$0.00	($0.46)	$0.87
Adjusted Weighted Average Basic Shares Outstanding	32.88M	33.57M	38.23M	43.77M	48.34M	52.55M	55.02M	55.46M	0.00	55.94M	56.23M
Adjusted Diluted Earnings per Share	$0.28	$0.34	$0.72	$0.37	$0.44	$1.11	$2.24	$3.24	$0.00	($0.46)	$0.86
Adjusted Weighted Average Diluted Shares Outstanding	33.58M	34.10M	39.15M	45.47M	49.21M	53.89M	57.26M	57.46M	0.00	55.94M	56.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	33.03M	33.85M	43.59M	43.92M	52.08M	54.77M	55.33M	55.56M	0.00	56.15M	56.33M
Normalized Net Operating Profit after Tax (NOPAT)	12	19	9.80	20	30	49	145	166	11	-22	33
Normalized NOPAT Margin	14.87%	9.19%	6.94%	10.38%	10.93%	13.34%	21.57%	20.74%	1.70%	-3.52%	4.41%
Pre Tax Income Margin	16.07%	5.59%	5.13%	11.05%	9.68%	16.17%	22.90%	27.34%	8.97%	-4.26%	8.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	416.22	4.01	2.07	3.91	2.39	6.34	14.60	183.58	3.15	-2.03	2.62
NOPAT to Interest Expense	299.45	4.24	8.51	3.00	1.98	6.56	12.39	164.07	1.97	-1.19	2.01
EBIT Less CapEx to Interest Expense	334.09	2.88	1.22	2.14	1.16	4.25	8.65	110.58	0.76	-3.27	1.54
NOPAT Less CapEx to Interest Expense	217.33	3.10	7.66	1.23	0.74	4.48	6.44	91.07	-0.41	-2.42	0.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.06%	6.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.06%	6.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	40.41%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,331,110.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,331,110.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.15
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-29.66%	-10.78%	-7.38%	-0.21%	9.69%	0.56%	10.44%	14.81%	21.91%	18.12%	14.83%
EBITDA Growth	-56.35%	-56.10%	-30.22%	-18.95%	13.68%	-213.26%	15.21%	37.51%	630.94%	243.64%	-9.63%
EBIT Growth	-88.76%	-80.11%	-102.00%	-75.54%	-200.59%	-523.11%	2,285.50%	258.77%	402.60%	143.09%	-82.85%
NOPAT Growth	-84.44%	-293.89%	-70.80%	-77.40%	-178.60%	70.66%	44.34%	227.66%	367.42%	148.62%	1,452.56%
Net Income Growth	-58.12%	-133.76%	-78.51%	-71.13%	-103.86%	-105.89%	76.88%	160.21%	2,379.97%	139.23%	42.93%
EPS Growth	-57.75%	-134.52%	-77.78%	-71.43%	-103.33%	-110.34%	66.67%	160.00%	2,700.00%	139.34%	50.00%
Operating Cash Flow Growth	-5.16%	-53.03%	300.82%	22.40%	25.72%	34.79%	-66.44%	-32.19%	-2.48%	-34.39%	88.57%
Free Cash Flow Firm Growth	46.49%	-121.22%	-42.13%	10.21%	-30.55%	107.31%	66.91%	10.14%	19.57%	-612.53%	197.74%
Invested Capital Growth	6.22%	13.91%	10.49%	7.27%	6.76%	-2.66%	3.35%	6.55%	6.17%	7.26%	1.14%
Revenue Q/Q Growth	-11.29%	18.01%	-1.64%	4.95%	0.52%	8.18%	0.97%	7.80%	3.53%	4.82%	-1.85%
EBITDA Q/Q Growth	-28.59%	9.69%	18.53%	85.15%	35.42%	-209.30%	189.83%	43.89%	32.22%	-49.59%	8.98%
EBIT Q/Q Growth	-73.67%	91.03%	72.15%	338.13%	-785.77%	-703.55%	114.19%	188.89%	-8.12%	14.41%	-94.35%
NOPAT Q/Q Growth	-54.91%	-1,348.46%	638.74%	72.05%	-675.29%	-366.05%	118.90%	134.90%	29.27%	-15.27%	503.46%
Net Income Q/Q Growth	-15.65%	-197.21%	112.93%	172.83%	-119.69%	-5,078.75%	117.21%	154.99%	0.30%	-10.89%	-37.28%
EPS Q/Q Growth	-14.29%	-196.67%	113.64%	150.00%	-116.67%	-6,000.00%	116.39%	160.00%	0.00%	-7.69%	-37.50%
Operating Cash Flow Q/Q Growth	13.82%	-25.91%	53.82%	-5.63%	16.90%	-20.57%	-61.70%	90.66%	68.13%	-46.56%	10.08%
Free Cash Flow Firm Q/Q Growth	37.57%	-242.07%	26.72%	26.65%	-9.50%	119.16%	-345.35%	-90.30%	10.07%	-22.06%	146.79%
Invested Capital Q/Q Growth	-0.77%	9.04%	-1.14%	-1.19%	-0.51%	-0.58%	5.33%	2.16%	-0.76%	0.45%	-0.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	25.89%	47.10%	50.13%	51.33%	50.03%	23.18%	53.65%	49.98%	53.24%	52.46%	55.74%
EBITDA Margin	18.16%	16.88%	13.35%	21.70%	18.82%	-19.02%	16.92%	22.58%	28.84%	13.87%	15.40%
Operating Margin	3.32%	5.93%	2.45%	3.44%	-5.06%	-21.79%	3.89%	7.62%	8.91%	9.03%	8.21%
EBIT Margin	3.63%	5.88%	-0.18%	2.98%	-3.33%	-24.73%	3.48%	9.31%	8.27%	9.02%	0.52%
Profit (Net Income) Margin	11.99%	-9.87%	2.15%	3.60%	-0.42%	-20.21%	3.45%	8.15%	7.90%	6.71%	4.29%
Tax Burden Percent	148.70%	-882.04%	89.20%	63.29%	56.92%	87.73%	73.40%	81.61%	87.14%	69.52%	470.26%
Interest Burden Percent	221.98%	19.04%	-1,373.61%	190.68%	22.28%	93.17%	135.11%	107.25%	109.66%	107.05%	175.79%
Effective Tax Rate	-48.70%	982.04%	10.80%	36.71%	0.00%	0.00%	26.60%	18.39%	12.86%	30.48%	-370.26%
Return on Invested Capital (ROIC)	2.06%	-19.49%	0.80%	0.77%	-1.27%	-5.43%	1.02%	2.29%	3.02%	2.54%	15.82%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.21%	-48.68%	0.82%	-0.11%	-2.94%	-0.97%	0.37%	0.43%	2.91%	2.15%	52.18%
Return on Net Nonoperating Assets (RNNOA)	0.19%	6.08%	-0.10%	0.01%	0.43%	0.09%	-0.03%	-0.04%	-0.32%	-0.23%	-4.67%
Return on Equity (ROE)	2.25%	-13.41%	0.70%	0.79%	-0.85%	-5.34%	0.99%	2.25%	2.69%	2.31%	11.14%
Cash Return on Invested Capital (CROIC)	-0.12%	-11.24%	-8.41%	-6.98%	-6.75%	1.32%	-4.54%	-7.26%	-5.97%	-4.64%	2.04%
Operating Return on Assets (OROA)	0.98%	1.39%	-0.04%	0.67%	-0.77%	-5.54%	0.79%	2.18%	2.03%	2.30%	0.14%
Return on Assets (ROA)	3.23%	-2.33%	0.50%	0.81%	-0.10%	-4.53%	0.79%	1.91%	1.94%	1.72%	1.13%
Return on Common Equity (ROCE)	2.25%	-13.41%	0.70%	0.79%	-0.85%	-5.34%	0.99%	2.25%	2.69%	2.31%	11.14%
Return on Equity Simple (ROE_SIMPLE)	5.76%	0.00%	1.50%	0.04%	-0.97%	0.00%	-1.16%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	6.98	-87	3.35	3.46	-5.48	-26	4.83	11	15	12	75
NOPAT Margin	4.94%	-52.26%	2.18%	2.18%	-3.54%	-15.25%	2.85%	6.22%	7.77%	6.28%	38.59%
Net Nonoperating Expense Percent (NNEP)	3.27%	29.19%	-0.02%	0.88%	1.66%	-4.46%	0.65%	1.86%	0.11%	0.40%	-36.36%
Return On Investment Capital (ROIC_SIMPLE)	-	-3.41%	-	-	-	-1.02%	0.19%	0.44%	0.56%	0.47%	2.82%
Cost of Revenue to Revenue	74.11%	52.90%	49.87%	48.67%	49.97%	76.82%	46.35%	50.02%	46.76%	47.54%	44.26%
SG&A Expenses to Revenue	39.37%	34.59%	40.35%	41.22%	48.82%	36.09%	42.12%	39.06%	39.02%	37.57%	39.40%
R&D to Revenue	7.49%	6.17%	7.34%	6.66%	6.27%	6.97%	7.64%	7.65%	7.51%	6.63%	7.44%
Operating Expenses to Revenue	22.57%	41.18%	47.68%	47.88%	55.09%	44.97%	49.76%	42.36%	44.33%	43.43%	47.54%
Earnings before Interest and Taxes (EBIT)	5.13	9.79	-0.27	4.73	-5.16	-41	5.88	17	16	18	1.01
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	26	28	20	34	29	-32	29	41	54	27	30
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.46	5.11	5.22	3.55	4.13	4.09	3.60	3.39	3.61	4.38	3.15
Price to Tangible Book Value (P/TBV)	11.43	17.59	17.55	11.49	12.86	14.83	14.47	12.90	13.08	15.23	10.53
Price to Revenue (P/Rev)	13.24	15.87	16.39	11.60	13.53	12.71	10.98	10.37	10.62	12.49	8.69
Price to Earnings (P/E)	77.40	282.01	347.66	9,159.58	0.00	0.00	0.00	0.00	4,326.79	188.65	129.13
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.29%	0.35%	0.29%	0.01%	0.00%	0.00%	0.00%	0.00%	0.02%	0.53%	0.77%
Enterprise Value to Invested Capital (EV/IC)	5.15	5.47	5.63	3.85	4.57	4.47	3.79	3.60	3.90	4.77	3.42
Enterprise Value to Revenue (EV/Rev)	12.74	15.62	16.11	11.26	13.13	12.37	10.78	10.12	10.33	12.20	8.39
Enterprise Value to EBITDA (EV/EBITDA)	49.55	83.20	86.81	76.70	93.70	182.00	149.45	117.26	69.56	59.35	43.12
Enterprise Value to EBIT (EV/EBIT)	81.49	206.90	246.98	957.11	0.00	0.00	0.00	0.00	0.00	159.86	124.47
Enterprise Value to NOPAT (EV/NOPAT)	89.83	329.94	378.73	10,997.55	0.00	0.00	0.00	0.00	24,586.06	208.23	108.54
Enterprise Value to Operating Cash Flow (EV/OCF)	58.16	86.73	68.46	44.05	48.93	44.76	48.12	51.61	55.88	76.68	49.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	334.54	0.00	0.00	0.00	0.00	168.61
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.30	0.31	0.30	0.27	0.28	0.28	0.26	0.26	0.26	0.26
Long-Term Debt to Equity	0.00	0.26	0.26	0.26	0.26	0.27	0.27	0.26	0.26	0.26	0.26
Financial Leverage	-0.16	-0.12	-0.12	-0.13	-0.15	-0.09	-0.08	-0.09	-0.11	-0.11	-0.09
Leverage Ratio	1.30	1.38	1.39	1.38	1.33	1.44	1.44	1.43	1.40	1.42	1.41
Compound Leverage Factor	2.89	0.26	-19.06	2.62	0.30	1.34	1.95	1.53	1.54	1.52	2.49
Debt to Total Capital	13.05%	23.17%	23.62%	23.25%	20.98%	21.57%	22.11%	20.72%	20.68%	20.63%	20.77%
Short-Term Debt to Total Capital	13.05%	3.22%	3.65%	3.23%	0.55%	0.68%	1.33%	0.20%	0.19%	0.19%	0.20%
Long-Term Debt to Total Capital	0.00%	19.95%	19.97%	20.02%	20.44%	20.89%	20.78%	20.52%	20.48%	20.43%	20.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.95%	76.83%	76.38%	76.75%	79.02%	78.43%	77.89%	79.28%	79.32%	79.38%	79.23%
Debt to EBITDA	1.73	4.99	5.23	6.74	6.21	12.58	12.01	9.27	5.16	3.61	3.72
Net Debt to EBITDA	-1.93	-1.34	-1.49	-2.33	-2.88	-4.98	-2.85	-2.92	-1.96	-1.45	-1.57
Long-Term Debt to EBITDA	0.00	4.30	4.42	5.81	6.04	12.19	11.29	9.18	5.12	3.57	3.68
Debt to NOPAT	3.14	19.79	22.80	967.14	-150.48	-22.08	-24.93	-32.27	1,825.35	12.66	9.35
Net Debt to NOPAT	-3.50	-5.30	-6.48	-334.64	69.80	8.73	5.92	10.18	-691.48	-5.10	-3.94
Long-Term Debt to NOPAT	0.00	17.04	19.28	832.94	-146.57	-21.38	-23.43	-31.96	1,808.19	12.54	9.26
Altman Z-Score	10.95	7.80	7.77	5.64	7.01	6.42	5.75	5.84	6.24	7.45	5.73
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.69	6.74	6.23	6.62	10.44	8.41	6.79	8.59	8.36	8.37	9.20
Quick Ratio	2.03	5.31	4.94	5.33	8.43	7.03	5.56	7.04	6.85	6.82	7.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-90	-308	-167	-117	-117	22	-55	-105	-94	-115	54
Operating Cash Flow to CapEx	467.82%	262.15%	535.68%	877.50%	706.29%	707.15%	426.16%	402.89%	1,022.95%	323.04%	600.74%
Free Cash Flow to Firm to Interest Expense	-220.46	-22.05	-33.16	-22.84	-22.93	4.12	-10.51	-19.62	-17.45	-20.98	9.67
Operating Cash Flow to Interest Expense	96.15	2.08	8.89	8.24	9.63	7.17	2.86	5.34	8.88	4.68	5.07
Operating Cash Flow Less CapEx to Interest Expense	75.60	1.29	7.23	7.30	8.27	6.16	2.19	4.02	8.02	3.23	4.23
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.27	0.24	0.23	0.22	0.23	0.22	0.23	0.23	0.25	0.26	0.26
Accounts Receivable Turnover	5.99	5.26	5.03	4.99	5.24	4.91	4.94	4.81	5.09	5.04	5.11
Inventory Turnover	1.57	1.61	1.57	1.61	1.62	2.08	2.06	2.17	2.26	2.25	2.17
Fixed Asset Turnover	3.56	3.18	3.15	2.98	3.05	3.13	3.24	3.39	3.62	3.84	4.14
Accounts Payable Turnover	16.13	15.02	15.44	15.50	15.84	13.92	15.85	16.15	15.23	11.33	11.70
Days Sales Outstanding (DSO)	60.98	69.38	72.60	73.21	69.67	74.29	73.84	75.87	71.67	72.36	71.48
Days Inventory Outstanding (DIO)	232.46	227.19	231.87	227.23	225.16	175.14	177.12	168.25	161.80	162.49	168.41
Days Payable Outstanding (DPO)	22.63	24.30	23.64	23.54	23.05	26.22	23.03	22.60	23.97	32.22	31.21
Cash Conversion Cycle (CCC)	270.80	272.28	280.83	276.90	271.78	223.21	227.93	221.52	209.50	202.63	208.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,656	1,806	1,792	1,775	1,768	1,758	1,852	1,892	1,877	1,886	1,873
Invested Capital Turnover	0.42	0.37	0.37	0.35	0.36	0.36	0.36	0.37	0.39	0.41	0.41
Increase / (Decrease) in Invested Capital	97	221	170	120	112	-48	60	116	109	128	21
Enterprise Value (EV)	8,534	9,880	10,096	6,836	8,086	7,850	7,011	6,818	7,314	9,003	6,404
Market Capitalization	8,866	10,039	10,269	7,044	8,335	8,064	7,144	6,988	7,520	9,224	6,637
Book Value per Share	$35.67	$35.19	$35.23	$35.52	$36.01	$35.21	$35.36	$36.70	$37.03	$37.42	$37.38
Tangible Book Value per Share	$13.91	$10.22	$10.49	$10.97	$11.58	$9.71	$8.80	$9.64	$10.22	$10.76	$11.19
Total Capital	2,287	2,557	2,573	2,586	2,552	2,515	2,549	2,601	2,626	2,653	2,657
Total Debt	299	593	608	601	536	543	563	539	543	547	552
Total Long-Term Debt	0.00	510	514	518	522	526	530	534	538	542	547
Net Debt	-332	-159	-173	-208	-248	-215	-134	-170	-206	-220	-233
Capital Expenditures (CapEx)	8.39	11	8.35	4.81	6.98	5.54	3.52	7.10	4.70	7.96	4.71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	283	278	263	256	253	199	217	230	222	239	256
Debt-free Net Working Capital (DFNWC)	914	1,029	1,043	1,065	1,037	956	914	939	970	1,007	1,040
Net Working Capital (NWC)	615	946	950	982	1,023	939	880	934	965	1,002	1,035
Net Nonoperating Expense (NNE)	-9.95	-71	0.05	-2.25	-4.83	8.32	-1.00	-3.52	-0.25	-0.87	67
Net Nonoperating Obligations (NNO)	-332	-159	-174	-209	-248	-215	-134	-170	-206	-220	-233
Total Depreciation and Amortization (D&A)	21	18	21	30	34	9.58	23	24	39	9.60	29
Debt-free, Cash-free Net Working Capital to Revenue	42.23%	43.89%	41.94%	42.20%	41.10%	31.37%	33.38%	34.15%	31.32%	32.37%	33.52%
Debt-free Net Working Capital to Revenue	136.41%	162.70%	166.52%	175.48%	168.36%	150.74%	140.57%	139.33%	137.09%	136.35%	136.29%
Net Working Capital to Revenue	91.83%	149.66%	151.55%	161.74%	166.10%	148.04%	135.37%	138.56%	136.37%	135.67%	135.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.33	($0.30)	$0.06	$0.10	($0.01)	($0.61)	$0.10	$0.26	$0.27	$0.24	$0.15
Adjusted Weighted Average Basic Shares Outstanding	55.77M	55.72M	55.79M	55.88M	56.01K	55.94M	56.12M	56.23M	56.27M	56.23M	56.35M
Adjusted Diluted Earnings per Share	$0.32	($0.29)	$0.06	$0.10	($0.01)	($0.61)	$0.10	$0.26	$0.26	$0.24	$0.15
Adjusted Weighted Average Diluted Shares Outstanding	56.94M	56.38M	56.53M	56.43M	56.01K	55.94M	56.56M	56.51M	56.53M	56.56M	56.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.83M	55.77M	55.88M	56.01M	56.03M	56.15M	56.18M	56.26M	56.29M	56.33M	56.41M
Normalized Net Operating Profit after Tax (NOPAT)	-21	7.40	3.35	3.46	-5.48	-23	4.83	4.86	11	11	12
Normalized NOPAT Margin	-14.68%	4.44%	2.18%	2.18%	-3.54%	-13.92%	2.85%	2.67%	5.85%	5.74%	6.23%
Pre Tax Income Margin	8.06%	1.12%	2.41%	5.68%	-0.74%	-23.04%	4.70%	9.99%	9.06%	9.66%	0.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.57	0.70	-0.05	0.93	-1.01	-7.59	1.12	3.17	2.88	3.25	0.18
NOPAT to Interest Expense	17.10	-6.24	0.67	0.68	-1.07	-4.68	0.92	2.12	2.71	2.26	13.44
EBIT Less CapEx to Interest Expense	-7.99	-0.09	-1.71	-0.01	-2.37	-8.60	0.45	1.85	2.01	1.80	-0.66
NOPAT Less CapEx to Interest Expense	-3.46	-7.04	-0.99	-0.26	-2.43	-5.69	0.25	0.79	1.84	0.81	12.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	40.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the notable takeaways from Repligen (RGEN) quarterly statements, focusing on trends across the last four years of reported quarters. The bullets highlight potential positive, neutral, and negative implications for investors, in that order.

Revenue improvement: Q4 2025 Operating Revenue was $197.9M, up from $167.5M in Q4 2024 (roughly an 18% year-over-year increase), signaling solid top-line growth.
Quarterly profitability: Q4 2025 net income was $13.3M with basic/diluted earnings per share of $0.24, reflecting ongoing profitability in the latest quarter.
Strong cash generation in 2025: Q3 2025 delivered the strongest quarterly operating cash flow in 2025 (~$48.1M), underscoring robust cash-generating capability into the year.
Healthy liquidity: Cash & equivalents stood around $0.75B in Q3 2025, up from $0.71B in Q2 2025 and $0.70B in Q1 2025, indicating solid liquidity buffers.
Manageable leverage with sizable equity: Long-term debt hovered around $0.53B–$0.54B in 2025, while total equity remained strong at roughly $2.08B (Total Common Equity around $2.06B in Q3 2025), suggesting a solid capital base relative to debt.
Solid equity base supports growth: Total equity and related metrics remained high (Total Common Equity about $2.06B and Total Equity around $2.08B in Q3 2025), signaling a strong balance sheet cushion for investing in growth.
Intangible asset footprint from acquisitions: Goodwill (~$1.11B) and intangible assets (~$395M) are substantial in the balance sheet, reflecting ongoing IP/acquisition activity that carries impairment risk if growth slows (neutral assessment for now).
Share count context: Weighted-average shares outstanding were around 56.0–56.1M (basic/diluted) in 2025, yielding mid-0.20s to mid-0.27s EPS across quarters, indicating modest dilution and a relatively stable share base (neutral).
Significant investing outflow in Q4 2025: Net Cash From Continuing Investing Activities was about -$208.7M (driven by acquisitions and other investments), reducing near-term free cash flow.
Cash burn in Q4 2025: Net Change in Cash & Equivalents was -$182.7M, reflecting the large investing outflow despite positive operating cash flow in earlier quarters, which could pressure liquidity if investing pace remains high.

05/21/26 03:12 AM ETAI Generated. May Contain Errors.

Repligen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Repligen's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Repligen's net income appears to be on an upward trend, with a most recent value of $48.89 million in 2025, rising from $9.35 million in 2015. The previous period was -$25.51 million in 2024. Check out Repligen's forecast to explore projected trends and price targets.

Repligen's total operating income in 2025 was $55.17 million, based on the following breakdown:

Total Gross Profit: $386.25 million
Total Operating Expenses: $331.08 million

Over the last 10 years, Repligen's total revenue changed from $83.54 million in 2015 to $738.26 million in 2025, a change of 783.7%.

Repligen's total liabilities were at $843.57 million at the end of 2025, a 1.6% decrease from 2024, and a 3,491.3% increase since 2015.

In the past 10 years, Repligen's cash and equivalents has ranged from $54.09 million in 2015 to $757.36 million in 2024, and is currently $566.02 million as of their latest financial filing in 2025.

Over the last 10 years, Repligen's book value per share changed from 3.73 in 2015 to 37.42 in 2025, a change of 904.2%.

Related Companies

Financial statements for NASDAQ:RGEN last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Repligen (RGEN) Financials

Financials Breakdown Chart

Key Financial Trends

Repligen Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Repligen (RGEN) Financials

Annual Income Statements for Repligen

Quarterly Income Statements for Repligen

Annual Cash Flow Statements for Repligen

Quarterly Cash Flow Statements for Repligen

Annual Balance Sheets for Repligen

Quarterly Balance Sheets for Repligen

Annual Metrics And Ratios for Repligen

Quarterly Metrics And Ratios for Repligen

Financials Breakdown Chart

Key Financial Trends

Repligen Financials - Frequently Asked Questions

When does Repligen's financial year end?

How has Repligen's net income changed over the last 10 years?

What is Repligen's operating income?

How has Repligen's revenue changed over the last 10 years?

How much debt does Repligen have?

How much cash does Repligen have?

How has Repligen's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools